help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUBBARD, R.
Right arrow Articles by BRITTON, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUBBARD, R.
Right arrow Articles by BRITTON, J.

Am. J. Respir. Crit. Care Med., Volume 161, Number 1, January 2000, 5-8

Lung Cancer and Cryptogenic Fibrosing Alveolitis
A Population-based Cohort Study

RICHARD HUBBARD, ANDREA VENN, SARAH LEWIS, and JOHN BRITTON

Division of Respiratory Medicine, Nottingham University, Nottingham, United Kingdom

Cryptogenic fibrosing alveolitis has been reported to be associated with an increased risk of lung cancer. However, it has recently become apparent that cigarette smoking may be a risk factor for cryptogenic fibrosing alveolitis as well as for lung cancer, and so may confound the association between these conditions. We have therefore estimated the independent increase in lung cancer incidence in patients with cryptogenic fibrosing alveolitis compared with the general population in a population-based cohort study involving 890 subjects with cryptogenic fibrosing alveolitis and 5,884 control subjects drawn from the United Kingdom General Practice Research Database. The incidence of lung cancer was markedly increased among patients with cryptogenic fibrosing alveolitis (rate ratio [RR] 7.31, 95% confidence interval [95% CI] 4.47 to 11.93, p < 0.001), and adjustment for previous smoking history had little effect on this odds ratio (adjusted RR: 8.25, 95% CI 4.70 to 11.48, p < 0.001). This increase in lung cancer incidence remained when the analysis was restricted to current smokers (RR 7.36, 95% CI 1.54 to 35.19, p = 0.012). This study provides clear evidence that the incidence of lung cancer is increased in patients with cryptogenic fibrosing alveolitis, and that this effect is independent of the effect of cigarette smoking. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study.




This article has been cited by other articles:


Home page
 Anticancer ResHome page
K. MIYAZAKI, H. SATOH, K. KURISHIMA, R. NAKAMURA, H. ISHIKAWA, K. KAGOHASHI, G. OHARA, and N. HIZAWA
Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
Anticancer Res, July 1, 2009; 29(7): 2671 - 2674.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Du, L. Jin, X. Han, Z. Song, H. Zhang, and W. Liang
Naringenin: A Potential Immunomodulator for Inhibiting Lung Fibrosis and Metastasis
Cancer Res., April 1, 2009; 69(7): 3205 - 3212.
[Abstract] [Full Text] [PDF]

Home page
 ACCP Pulmonary Med Brd RevHome page
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 635 - 686.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A. W. Fogarty
The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease: A Population-based Study
Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1257 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Watanabe, T. Higami, S. Ohori, T. Koyanagi, S. Nakashima, and T. Mawatari
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1357 - 1363.e2.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. A. Shvedova, E. Kisin, A. R. Murray, V. J. Johnson, O. Gorelik, S. Arepalli, A. F. Hubbs, R. R. Mercer, P. Keohavong, N. Sussman, et al.
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L552 - L565.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F Calabrese, F Lunardi, C Giacometti, G Marulli, M Gnoato, P Pontisso, M Saetta, M Valente, F Rea, E Perissinotto, et al.
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations
Thorax, September 1, 2008; 63(9): 795 - 802.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax, September 1, 2008; 63(Suppl_5): v1 - v58.
[Full Text] [PDF]

Home page
 QJMHome page
M. Solaymani-Dodaran, J. West, C. Smith, and R. Hubbard
Extrinsic allergic alveolitis: incidence and mortality in the general population
QJM, April 1, 2007; 100(4): 233 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
E. K Pontifex, C. L Hill, and P. Roberts-Thomson
Risk factors for lung cancer in patients with scleroderma: a nested case-control study
Ann Rheum Dis, April 1, 2007; 66(4): 551 - 553.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Subramanian and R. Govindan
Lung Cancer in Never Smokers: A Review
J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R. M Rudd, R. J Prescott, J C Chalmers, I. D A Johnston, and for the Fibrosing Alveolitis Subcommittee of the R
British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival
Thorax, January 1, 2007; 62(1): 62 - 66.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Gribbin, R B Hubbard, I Le Jeune, C J P Smith, J West, and L J Tata
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Thorax, November 1, 2006; 61(11): 980 - 985.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. F. Pinsky, M. Freedman, P. Kvale, M. Oken, N. Caporaso, and J. Gohagan
Abnormalities on chest radiograph reported in subjects in a cancer screening trial.
Chest, September 1, 2006; 130(3): 688 - 693.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Tiitto, U. Heiskanen, R. Bloigu, P. Paakko, V. Kinnula, and R. Kaarteenaho-Wiik
Thoracoscopic Lung Biopsy Is a Safe Procedure in Diagnosing Usual Interstitial Pneumonia
Chest, October 1, 2005; 128(4): 2375 - 2380.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. C. Hall, C. M. Roberts, M. Boulis, J. Mo, and K. D. MacRae
Diabetes and the Risk of Lung Cancer
Diabetes Care, March 1, 2005; 28(3): 590 - 594.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Lantuejoul, T.V. Colby, G.R. Ferretti, P.Y. Brichon, C. Brambilla, and E. Brambilla
Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Eur. Respir. J., September 1, 2004; 24(3): 502 - 505.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. C. Hall, M. M. Brown, J. Mo, and K. D. MacRae
Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice
Neurology, February 24, 2004; 62(4): 563 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
L Smeeth, M Boulis, R Hubbard, and A E Fletcher
A population based case-control study of cataract and inhaled corticosteroids
Br J Ophthalmol, October 1, 2003; 87(10): 1247 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. M. Ross
The Clinical Diagnosis of Asbestosis in This Century Requires More Than a Chest Radiograph
Chest, September 1, 2003; 124(3): 1120 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Suzuki, K. Aoshiba, N. Yokohori, and A. Nagai
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Augments a Murine Model of Pulmonary Fibrosis
Cancer Res., August 15, 2003; 63(16): 5054 - 5059.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Kumar, P. Goldstraw, K. Yamada, A. G. Nicholson, A. U. Wells, D. M. Hansell, R. M. duBois, and G. Ladas
Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1321 - 1327.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Thomas, D. Price, T. McKeever, S. Lewis, and R. Hubbard
Prenatal antibiotic exposure and subsequent atopy
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1578 - 1579.
[Full Text]

Home page
 QJMHome page
L. Smeeth, R. Hubbard, and A.E. Fletcher
Cataract and the use of statins: a case-control study
QJM, May 1, 2003; 96(5): 337 - 343.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Dona, I. Dell'Aica, F. Calabrese, R. Benelli, M. Morini, A. Albini, and S. Garbisa
Neutrophil Restraint by Green Tea: Inhibition of Inflammation, Associated Angiogenesis, and Pulmonary Fibrosis
J. Immunol., April 15, 2003; 170(8): 4335 - 4341.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. J. Thannickal, D. Y. Lee, E. S. White, Z. Cui, J. M. Larios, R. Chacon, J. C. Horowitz, R. M. Day, and P. E. Thomas
Myofibroblast Differentiation by Transforming Growth Factor-beta 1 Is Dependent on Cell Adhesion and Integrin Signaling via Focal Adhesion Kinase
J. Biol. Chem., March 28, 2003; 278(14): 12384 - 12389.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. Martinod, J. F. Azorin, D. Sadoun, M.-D. Destable, P. Le Toumelin, E. Longchampt, M. Kambouchner, L. Guillevin, and D. Valeyre
Surgical resection of lung cancer in patients with underlying interstitial lung disease
Ann. Thorac. Surg., October 1, 2002; 74(4): 1004 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
M.-C. Aubry, J. L. Myers, W. W. Douglas, H. D. Tazelaar, T. L. W. Stephens, T. E. Hartman, C. Deschamps, and V. S. Pankratz
Primary Pulmonary Carcinoma in Patients With Idiopathic Pulmonary Fibrosis
Mayo Clin. Proc., August 1, 2002; 77(8): 763 - 770.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
R. Hubbard and A. Venn
The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis
Rheumatology, June 1, 2002; 41(6): 676 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804.
[Full Text] [PDF]

Home page
 NEJMHome page
H. M. Hollingsworth and E. J. Mark
Case 32-2001- A 77-Year-Old Man with Rheumatoid Arthritis and Acute Dyspnea and Renal Failure
N. Engl. J. Med., October 18, 2001; 345(16): 1193 - 1200.
[Full Text] [PDF]

Home page
 ChestHome page
J.-B. Stern, H. Mal, O. Groussard, O. Brugiere, A. Marceau, G. Jebrak, and M. Fournier
Prognosis of Patients With Advanced Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation for Acute Respiratory Failure
Chest, July 1, 2001; 120(1): 213 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Demedts, A.U. Wells, J.M. Anto, U. Costabel, R. Hubbard, P. Cullinan, H. Slabbynck, G. Rizzato, V. Poletti, E.K. Verbeken, et al.
Interstitial lung diseases: an epidemiological overview
Eur. Respir. J., July 1, 2001; 18(32_suppl): 2S - 16s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.M. du Bois and A.U. Wells
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Park, D.S. Kim, T.S. Shim, C-M. Lim, Y. Koh, S.D. Lee, W.S. Kim, W.D. Kim, J.S. Lee, and K.S. Song
Lung cancer in patients with idiopathic pulmonary fibrosis
Eur. Respir. J., June 1, 2001; 17(6): 1216 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Clark, B Cooper, S Singh, M Cooper, A Carr, and R Hubbard
A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis
Thorax, June 1, 2001; 56(6): 482 - 486.
[Abstract] [Full Text]

Home page
 Eur Respir JHome page
J.H. Ryu, T.V. Colby, T.E. Hartman, and R. Vassallo
Smoking-related interstitial lung diseases: a concise review
Eur. Respir. J., January 1, 2001; 17(1): 122 - 132.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R. Hubbard and A. Venn
Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK General Practice Research Database
Thorax, October 1, 2000; 55(10): 864 - 866.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. M. Samet
Does Idiopathic Pulmonary Fibrosis Increase Lung Cancer Risk?
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 1 - 1.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2000 American Thoracic Society 		  ATS 2008 State of the Art Course